U.K. panel allows ReNeuron to conduct trial of stem cell therapy

02/10/2010 | Reuters

The U.K. Gene Therapy Advisory Committee gave ReNeuron final approval to begin a clinical trial that involves injecting fetus-derived neural stem cells into the brains of disabled stroke patients. The biotech firm plans to test the ReN001 cell therapy on 12 patients who suffered ischemic strokes.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC